[化疗的双面性：对阿贝尔论文的评论] - Suppr

Suppr

超能文献

[Janus-faced character of chemotherapy: a comment on the Abel theses].

作者信息

Schmähl D

机构信息

Institut für Toxikologie und Chemotherapie, Deutsches Krebsforschungszentrum, Heidelberg.

出版信息

Klin Wochenschr. 1991 Jan 4;69(1):49-51. doi: 10.1007/BF01649059.

DOI:10.1007/BF01649059

PMID:2016847

Abstract

摘要

相似文献

[Janus-faced character of chemotherapy: a comment on the Abel theses].[化疗的双面性：对阿贝尔论文的评论]

Klin Wochenschr. 1991 Jan 4;69(1):49-51. doi: 10.1007/BF01649059.

The prognosis of prognostic factors in phase I clinical trials.I期临床试验中预后因素的预后情况。

Ann Oncol. 2000 Feb;11(2):131-2. doi: 10.1023/a:1008327527877.

[Clinical phase I studies in oncology and hematology. Concepts, implementation and ethical considerations].

Med Klin (Munich). 1996 Apr 12;91 Suppl 3:68-70.

The evolution of curative cancer therapy.癌症治疗方法的演变。

Mt Sinai J Med. 1992 Oct;59(5):408-11.

Cytotoxic drugs: the search for dose response.

Lancet. 1993 Mar 6;341(8845):614-6. doi: 10.1016/0140-6736(93)90366-o.

[The significance of the dosage strength in the response to cytotoxic drugs].[剂量强度在细胞毒性药物反应中的意义]

Med Clin (Barc). 1991 Mar 16;96(10):374-6.

Improving taste sensation in patients who have undergone chemotherapy or radiation therapy.改善接受过化疗或放疗患者的味觉。

J Am Diet Assoc. 2006 Oct;106(10):1536-40. doi: 10.1016/j.jada.2006.07.021.

[Rationalization of adjuvant chemotherapy by induction chemotherapy].诱导化疗对辅助化疗的合理化应用

Bull Cancer. 1984;71(4):297-300.

Minimalism in oncology.肿瘤学中的极简主义。

Lancet Oncol. 2018 May;19(5):579. doi: 10.1016/S1470-2045(18)30282-1.

Validation of a new risk assessment model for predicting adverse events in children with fever and chemotherapy-induced neutropenia.一种用于预测发热且化疗引起中性粒细胞减少症儿童不良事件的新风险评估模型的验证

J Clin Oncol. 2011 Mar 1;29(7):e182-4; author reply e185. doi: 10.1200/JCO.2010.32.7767. Epub 2011 Jan 18.

本文引用的文献

[Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].[2-巯基乙烷磺酸钠（美司钠）预防膀胱肿瘤形成。实验研究及临床结果]

Urologe A. 1984 Sep;23(5):291-6.

[Postoperative immunostimulation in non-small-cell bronchial carcinoma. Outcome and complications].[非小细胞支气管癌术后免疫刺激。结果与并发症]

Dtsch Med Wochenschr. 1984 Jun 15;109(24):935-40.

[Secondary tumors following cytostatic chemotherapy with alkylating agents in man; the toxicological viewpoints].[人类使用烷化剂进行细胞抑制化疗后的继发性肿瘤；毒理学观点]

Dtsch Med Wochenschr. 1986 May 23;111(21):833-5. doi: 10.1055/s-2008-1068542.

[Postoperative fever and prognosis in breast cancer].[乳腺癌术后发热与预后]

Arch Geschwulstforsch. 1987;57(4):309-17.

[Importance of the composition of various combination regimens in the chemotherapy of metastatic breast cancer].[不同联合方案组成在转移性乳腺癌化疗中的重要性]

Dtsch Med Wochenschr. 1987 Feb 13;112(7):270-5. doi: 10.1055/s-2008-1068044.

No relevant influence on overall survival time in patients with metastatic breast cancer undergoing combination chemotherapy.对接受联合化疗的转移性乳腺癌患者的总生存时间无相关影响。

J Cancer Res Clin Oncol. 1988;114(2):183-5. doi: 10.1007/BF00417834.

[Chemotherapy of metastasized breast carcinoma].[转移性乳腺癌的化疗]

Dtsch Med Wochenschr. 1988 Feb 12;113(6):224-31. doi: 10.1055/s-2008-1067624.

Anticancer drugs: second malignancies--risk reduction.抗癌药物：二次恶性肿瘤——风险降低

Cancer Treat Rev. 1987 Dec;14(3-4):337-43. doi: 10.1016/0305-7372(87)90027-2.

Non-chemotherapeutic agents that potentiate chemotherapy efficacy.增强化疗疗效的非化疗药物。

Cancer Treat Rev. 1989 Mar;16(1):1-40. doi: 10.1016/0305-7372(89)90002-9.

Treatment of the terminal stages of breast cancer.乳腺癌晚期的治疗。

BMJ. 1989 Jan 7;298(6665):13-4. doi: 10.1136/bmj.298.6665.13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验